Notice of Availability of Administrative Supplements to NIBIB C3i Participants for Advancing Innovation

Notice Number: NOT-EB-18-018

Key Dates
Release Date: June 5, 2018

Related Announcements
PA-18-591

Issued by
National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Purpose

The National Institute of Biomedical Imaging and Bioengineering (NIBIB) announces the opportunity for investigators with active NIBIB-supported research project grants (R01), who have recently completed the Concept to Clinic: Commercializing Innovation (C3i) Program, to submit administrative supplement requests to accelerate technology development and translational research aims consistent with the peer-reviewed objectives of the parent grant.  Investigators may propose research and development efforts that incorporate the learnings from the C3i Program and take advantage of unanticipated opportunities to increase the value of the project.

Administrative supplement requests should be submitted to PA-18-591, Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) https://grants.nih.gov/grants/guide/pa-files/PA-18-591.html. NIBIB will consider supplements that do not exceed $100,000 in direct costs for up to 12 months. The project and budget periods of the supplement request must be within the currently approved project period for the existing parent award. Administrative supplements must add value to the science proposed in the aims of the original project, as such they must be within the scientific scope of the parent grant.

These administrative supplements are available to meet increased costs that are within the scope of the approved award, but were unforeseen when the application was submitted. Applicants are strongly encouraged to discuss the aims of the proposed work with the NIBIB program officer assigned to the parent grant to assess suitability for this funding opportunity.

Applicants should begin their application by stating: "This application is being submitted in response to NOT-EB-18-018".

Requests must be received by July 24, 2018.

Inquiries

Please direct all inquiries to:

Todd Merchak
National Institute of Biomedical Imaging and Bioengineering
Telephone: 301-496-8592
Email: todd.merchak@nih.gov